SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-009167
Filing Date
2021-01-14
Accepted
2021-01-14 17:22:28
Documents
6
Period of Report
2021-01-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d112118d8k.htm 8-K 25759
2 EX-1.1 d112118dex11.htm EX-1.1 154460
3 EX-5.1 d112118dex51.htm EX-5.1 13206
4 EX-99.1 d112118dex991.htm EX-99.1 8454
5 EX-99.2 d112118dex992.htm EX-99.2 8313
6 GRAPHIC g112118evoke.jpg GRAPHIC 20095
  Complete submission text file 0001193125-21-009167.txt   239118
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 21529670
SIC: 2834 Pharmaceutical Preparations